CSIMarket

Bard C R Inc  (BCR)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 75
 Employees 13,900
 Revenues (TTM) (Millions $) 3,941
 Net Income (TTM) (Millions $) 817
 Cash Flow (TTM) (Millions $) -91
 Capital Exp. (TTM) (Millions $) 127

Bard C R Inc
C. R. Bard, Inc. Is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. Charles Russell Bard started the company in 1907. One of its first medical products was the silk urethral catheter imported from France. In 1923, the company was incorporated as C. R. Bard, Inc. and distributed an assortment of urology and surgical products. Bard became a publicly traded company in 1963 and five years later was traded on the New York Stock Exchange. Today, the company markets its products worldwide to hospitals, individual health care professionals, extended care facilities and alternate site facilities. In general, the company's products are intended to be used once and then discarded. Bard holds strong market positions in vascular, urology, oncology and surgical specialty products.

Bard has an acquisition strategy that targets small research or developing companies as well as larger, established companies with market leadership positions. In addition to acquiring companies, Bard has expanded its business in the medical field by acquiring product lines, entering into licensing agreements and joint ventures and making equity investments in companies with emerging technologies.

International

Bard markets its products through 23 subsidiaries and a joint venture in over 90 countries outside the United States. The products sold in the company's international markets include many of the products described above under Product Group Information. However, the principal markets, products and methods of distribution in the company's international businesses vary with market size and stage of development. The company's principal international markets are in Europe and Japan. The company believes that its geographically-based sales organization gives the company greater flexibility in international markets. Approximately 58% of international sales are of products manufactured by Bard in the United States, Puerto Rico or Mexico.

Competition

The company competes in the therapeutic and diagnostic medical markets both in the United States and around the world. These markets are characterized by rapid change resulting from technological advances and scientific discoveries. The company depends more on its consistently reliable product quality, dependable service and its ability to develop products to meet market needs than on patent protection, although many of its products are patented or are the subject of patent applications. The company faces a mix of competitors ranging from large manufacturers with multiple business lines to smaller manufacturers that offer a limited selection of products. In addition, the FDA has recently increased its oversight of companies involved with the reprocessing of single-use medical devices and has provided improved guidance to reprocessors, thereby facilitating the reprocessing business.



   


Customers Net Income grew by BCR's Customers Net Profit Margin fell to

6.75 %

1.13 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

Year to Date Decrease / Increase
     
BSX   -7.49%    
EW   -26.51%    
MDT   -1.73%    
VAR        1.11% 
ABBV        9.31% 
ABT   -17.27%    
BMY        23.95% 
DHR   -19.84%    
JNJ        4.61% 
• View Complete Report
   



Dss Inc.

Bewildering306.17%, Sales gain, by Dss Inc in the most recent fiscal period

In the most recent fiscal period Dss Inc decreased loss of $-0.10 per share compared to $-0.27 a year ago and improved from $-0.20 per share from the previous quarter.

The Glimpse Group Inc.

Logged a Loss by The Glimpse Group Inc in the third quarter of 2022 report

The Glimpse Group Inc reported disappointing third quarter of 2022, where Sales melted down by -40.02% to $2.05 millions and company posted loss per share to $-0.14, compared to $-0.84, in the same quarter a year ago.

Adhera Therapeutics Inc.

Redemption of Losses but Revenues Unchanged at Adhera Therapeutics Inc in the fiscal period ending Mar 31 2022

In the fiscal period ending Mar 31 2022 Adhera Therapeutics Inc decreased loss of $-0.03 per share compared to $-0.84 a year ago and improved from $-0.32 per share from the previous quarter.

Isun Inc.

Isun Inc disclosed first quarter of 2022 operating deficit of $-5.703 millions

Isun Inc announced very strong Sales growth of 107.79% year on year to $15.09 millions in the first quarter of 2022, but lost money at $-0.23.

Flexible Solutions International Inc.

EPS Unchanged, Sharp Top-line Growth

In the first quarter of 2022 Flexible Solutions International Inc eps remained unchanged of $0.12 per share compared to $0.12 a year ago and EPS turn positive from $-0.03 per share from the previous quarter.






 

Bard C R Inc's Segments
 
Vascular
 Segment    28.94 % of total Revenue
Urology
 Segment    24.52 % of total Revenue
Oncology
 Segment    27.64 % of total Revenue
Surgery
 Segment    16.15 % of total Revenue
Other products
 Segment    2.75 % of total Revenue
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Bard C R Inc does not provide revenue guidance.

Earnings Outlook
Flexible Solutions International Inc. does not provide earnings estimates.

 
Geographic Revenue Dispersion
United States 68.1 %
Europe 14.7 %
Japan 4.95 %
Rest of the World 12.25 %


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CYRN's Profile

Stock Price

CYRN's Financials

Business Description

Fundamentals

Charts & Quotes

CYRN's News

Suppliers

CYRN's Competitors

Customers & Markets

Economic Indicators

CYRN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071